2- (4- (6- chloro- 1,3- benzoxazol- 2- yloxy)phenoxy)- 2'- fluoro- N- methylpropionanilide

metamifop is the (R)-isomer; an herbicide; structure in first source

Also Known As:

metamifop

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aniline Compounds: 46
    - Anilides: 22
      - 2-(4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy)-2'-fluoro-N-methylpropionanilide: 3
- Amides: 2428
  - Anilides: 22
    - 2-(4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy)-2'-fluoro-N-methylpropionanilide: 3
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzoxazoles: 68
      - 2-(4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy)-2'-fluoro-N-methylpropionanilide: 3

Experts

1.	Duan, Manman: 1 article (09/2022)
2.	Guo, Mengyu: 1 article (09/2022)
3.	Liu, Yinchi: 1 article (09/2022)
4.	Qiu, Lihong: 1 article (09/2022)
5.	Zhang, Mengna: 1 article (09/2022)
6.	Zhao, Feng: 1 article (09/2022)
7.	Zheng, Junyue: 1 article (09/2022)
8.	Diao, Jinling: 1 article (09/2021)
9.	Liu, Rui: 1 article (09/2021)
10.	Qin, Yinan: 1 article (09/2021)

Related Diseases

1.	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 09/01/2022 - "Previous studies have demonstrated that sublethal metamifop exposures induce hepatic lipid metabolism disorder in zebrafish. "
2.	Body Weight (Weight, Body) 11/01/2014 - "Males and females fed 750ppm of metamifop for 104weeks showed decreases in body weight and body weight gain. " 09/01/2021 - "After 14, 21 and 35 d of exposure, metamifop significantly inhibited the body weight and neurotransmitter synthesis of tadpoles, caused abnormal behavior and interfered with fat metabolism. "
3.	Fibroadenoma 11/01/2014 - "Histopathological examination revealed that treatment with metamifop reduced non-neoplastic findings (chronic progressive nephropathy, tubular basophilia, tubular casts, glomerulosclerosis, basophilic and clear cell foci, senile atrophy, and mesothelial hyperplasia) and reduced neoplastic findings (thymoma, pituitary adenoma, and mammary fibroadenoma and adenocarcinoma in females, and mesenteric lymph node hemangioma in males) compared with control groups. "
4.	Thymoma (Thymic Carcinoma) 11/01/2014 - "Histopathological examination revealed that treatment with metamifop reduced non-neoplastic findings (chronic progressive nephropathy, tubular basophilia, tubular casts, glomerulosclerosis, basophilic and clear cell foci, senile atrophy, and mesothelial hyperplasia) and reduced neoplastic findings (thymoma, pituitary adenoma, and mammary fibroadenoma and adenocarcinoma in females, and mesenteric lymph node hemangioma in males) compared with control groups. "
5.	Pituitary Neoplasms (Pituitary Adenoma) 11/01/2014 - "Histopathological examination revealed that treatment with metamifop reduced non-neoplastic findings (chronic progressive nephropathy, tubular basophilia, tubular casts, glomerulosclerosis, basophilic and clear cell foci, senile atrophy, and mesothelial hyperplasia) and reduced neoplastic findings (thymoma, pituitary adenoma, and mammary fibroadenoma and adenocarcinoma in females, and mesenteric lymph node hemangioma in males) compared with control groups. "

Related Drugs and Biologics

1.	Gonadal Hormones
2.	Neurotransmitter Agents (Neurotransmitter)